You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NEWS / EVENTS / .........

EVENTS - 05-07-2019

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy


More than a thousand experts from all over the world attended the 2019 Peripheral Nerve Society (PNS) Annual Meeting in Genoa (Italy) on 22-25 June. Kedrion Biopharma joined in this event with a delegation of 50 international guests coming from Austria, Germany, Italy, Poland, Portugal, Serbia, Turkey and United Arab Emirates. A Kedrion scientific symposium, held on June 23rd, offered Key Opinion Leaders the opportunity to share their experiences and comment on new possible therapeutic options for the treatment of Chemotherapy-Induced Peripheral Neurotoxicity (CIPN). The discussion, which was moderated by Professor Eduardo Nobile-Orazio (Istituto Humanitas, Milan, Italy) and Professor Angelo Schenone (University of Genoa, Italy), opened with a contribution by Andreas Argyriou, MD (Saint Andrews General Hospital, Patras, Greece) on the main unmet clinical needs in the prevention and treatment of CIPN; then, Professor Guido Cavaletti (University of Bicocca, Monza, Italy) described preliminary results for the treatment of CIPN in animals; finally, also Professor Nathan Staff (Mayo Clinic, Rochester, Minnesota, USA) focused on the treatment of these kinds of toxic neuropathies.  




For more information please contact: